BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25931402)

  • 21. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome.
    Gulácsy V; Freiberger T; Shcherbina A; Pac M; Chernyshova L; Avcin T; Kondratenko I; Kostyuchenko L; Prokofjeva T; Pasic S; Bernatowska E; Kutukculer N; Rascon J; Iagaru N; Mazza C; Tóth B; Erdos M; van der Burg M; Maródi L;
    Mol Immunol; 2011 Feb; 48(5):788-92. PubMed ID: 21185603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
    Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
    J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.
    Kolluri R; Shehabeldin A; Peacocke M; Lamhonwah AM; Teichert-Kuliszewska K; Weissman SM; Siminovitch KA
    Hum Mol Genet; 1995 Jul; 4(7):1119-26. PubMed ID: 8528198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.
    Zhu Q; Zhang M; Blaese RM; Derry JM; Junker A; Francke U; Chen SH; Ochs HD
    Blood; 1995 Nov; 86(10):3797-804. PubMed ID: 7579347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wiskott-Aldrich syndrome protein and platelets.
    Oda A; Ochs HD
    Immunol Rev; 2000 Dec; 178():111-7. PubMed ID: 11213795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical and molecular characteristics of Wiskott-Aldrich syndrome in 24 patients from 23 unrelated Chinese families.
    Zhang ZY; Xiao HQ; Jiang LP; Zhou Y; Zhao Q; Yu J; Liu W; Yang XQ; Zhao XD
    Pediatr Allergy Immunol; 2010 May; 21(3):522-32. PubMed ID: 20546529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
    Imai K; Nonoyama S; Ochs HD
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome.
    Lutskiy MI; Rosen FS; Remold-O'Donnell E
    J Immunol; 2005 Jul; 175(2):1329-36. PubMed ID: 16002738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
    Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
    Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype.
    Linder S; Wintergerst U; Bender-Götze C; Schwarz K; Pannicke U; Aepfelbacher M
    Immunol Cell Biol; 2003 Apr; 81(2):130-6. PubMed ID: 12631236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel protocol to identify mutations in patients with wiskott-Aldrich syndrome.
    Jones LN; Lutskiy MI; Cooley J; Kenney DM; Rosen FS; Remold-O'Donnell E
    Blood Cells Mol Dis; 2002; 28(3):392-8. PubMed ID: 12367583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene.
    Villa A; Notarangelo L; Macchi P; Mantuano E; Cavagni G; Brugnoni D; Strina D; Patrosso MC; Ramenghi U; Sacco MG
    Nat Genet; 1995 Apr; 9(4):414-7. PubMed ID: 7795648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
    Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
    Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.
    Okuya M; Kurosawa H; Kubota T; Endoh K; Ogiwara A; Nonoyama S; Hagisawa S; Sato Y; Matsushita T; Fukushima K; Sugita K; Sato T; Arisaka O
    Bone Marrow Transplant; 2010 Mar; 45(3):607-9. PubMed ID: 19684625
    [No Abstract]   [Full Text] [Related]  

  • 39. WASP and the phenotypic range associated with deficiency.
    Notarangelo LD; Notarangelo LD; Ochs HD
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):485-90. PubMed ID: 16264326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.